Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

Open access
Göke, R, Fehmann, H.C., Linn, T, Schmidt, H, Krause, M, Eng, J, Göke, B·1993·Journal of Biological Chemistry

Abstract

Exendin-4 purified from Heloderma suspectum venom shows structural relationship to the important incretin hormone glucagon-like peptide 1-(7-36)-amide (GLP-1). We demonstrate that exendin-4 and truncated exendin-(9-39)-amide specifically interact with the GLP-1 receptor on insulinoma-derived cells and on lung membranes. Exendin-4 displaced 125I-GLP-1, and unlabeled GLP-1 displaced 125I-exendin-4 from the binding site at rat insulinoma-derived RINm5F cells. Exendin-4 had, like GLP-1, a pronounced effect on intracellular cAMP generation, which was reduced by exendin-(9-39)-amide. When combined, GLP-1 and exendin-4 showed additive action on cAMP. They each competed with the radio-labeled version of the other peptide in cross-linking experiments. The apparent molecular mass of the respective ligand-binding protein complex was 63,000 Da. Exendin-(9-39)-amide abolished the cross-linking of both peptides. Exendin-4, like GLP-1, stimulated dose dependently the glucose-induced insulin secretion in isolated rat islets, and, in mouse insulinoma beta TC-1 cells, both peptides stimulated the proinsulin gene expression at the level of transcription. Exendin-(9-39)-amide reduced these effects. In conclusion, exendin-4 is an agonist and exendin-(9-39)-amide is a specific GLP-1 receptor antagonist.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(19)36565-2

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 3

  1. Zunz, 1929, Arch. Int. Physiol. Biochim., 31, 20
  2. Richter, 1993, Am. J. Physiol.
  3. Fehmann, 1992, Endocrinology, 130, 159, 10.1210/endo.130.1.1309325 · doi:10.1210/endo.130.1.1309325 · Paper page

Cited by

See all 837

Metadata

Authors
Göke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., & Göke, B.
Affiliations
Philipps University of Marburg (DE)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1993-09
Volume
268
Issue
26
Pages
19650-19655
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1909310469
Cited by
837
References
30
Citations by year
2026: 12 · 2025: 19 · 2024: 23 · 2023: 26 · 2022: 17 · 2021: 30 · 2020: 20 · 2019: 34 · 2018: 17 · 2017: 27 · 2016: 44 · 2015: 36 · 2014: 38 · 2013: 48 · 2012: 37
FWCI
9.87
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
exendin-4, GLP-1 receptor, glucagon-like peptide-1, insulinoma, pancreatic beta cells, insulin secretion, cAMP signaling, receptor antagonism, receptor agonism, incretins
MeSH terms
Glucagon-Like Peptide-1 Receptor, Exenatide, Insulin Secretion, Cyclic AMP, Animals, Binding, Competitive, Cell Line, Cell Membrane, Glucagon-Like Peptides, Glucagon, Insulin, Insulinoma, Kinetics, Lizards, Lung, Pancreatic Neoplasms, Peptide Fragments, Peptides, Receptors, Cell Surface, Tumor Cells, Cultured, Venoms, Receptors, Glucagon, Rats, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. https://app.cochat.ai/papers/10.1016/s0021-9258(19)36565-2
The paper
Göke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., & Göke, B. (1993). Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(19)36565-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.